S.Biomedics Statistics

Total Valuation

S.Biomedics has a market cap or net worth of KRW 278.71 billion. The enterprise value is 279.61 billion.

Market Cap	278.71B
Enterprise Value	279.61B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

S.Biomedics has 11.86 million shares outstanding. The number of shares has increased by 3.53% in one year.

Current Share Class	11.86M
Shares Outstanding	11.86M
Shares Change (YoY)	+3.53%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	21.89%
Owned by Institutions (%)	0.45%
Float	8.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.88
PB Ratio	16.06
P/TBV Ratio	27.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-39.51
EV / Sales	17.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-76.52

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 1.09.

Current Ratio	2.41
Quick Ratio	2.17
Debt / Equity	1.09
Debt / EBITDA	n/a
Debt / FCF	-5.19
Interest Coverage	-6.76

Financial Efficiency

Return on equity (ROE) is -41.35% and return on invested capital (ROIC) is -11.14%.

Return on Equity (ROE)	-41.35%
Return on Assets (ROA)	-8.99%
Return on Invested Capital (ROIC)	-11.14%
Return on Capital Employed (ROCE)	-16.68%
Revenue Per Employee	299.79M
Profits Per Employee	-136.09M
Employee Count	52
Asset Turnover	0.42
Inventory Turnover	3.01

Taxes

In the past 12 months, S.Biomedics has paid 63.79 million in taxes.

Income Tax	63.79M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.40% in the last 52 weeks. The beta is 1.57, so S.Biomedics's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	-46.40%
50-Day Moving Average	20,985.80
200-Day Moving Average	24,089.85
Relative Strength Index (RSI)	46.82
Average Volume (20 Days)	145,539

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S.Biomedics had revenue of KRW 15.59 billion and -7.08 billion in losses. Loss per share was -609.63.

Revenue	15.59B
Gross Profit	7.69B
Operating Income	-5.38B
Pretax Income	-5.82B
Net Income	-7.08B
EBITDA	-3.59B
EBIT	-5.38B
Loss Per Share	-609.63

Full Income Statement

Balance Sheet

The company has 24.95 billion in cash and 18.96 billion in debt, giving a net cash position of 5.99 billion or 505.07 per share.

Cash & Cash Equivalents	24.95B
Total Debt	18.96B
Net Cash	5.99B
Net Cash Per Share	505.07
Equity (Book Value)	17.36B
Book Value Per Share	882.14
Working Capital	17.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.42 billion and capital expenditures -1.23 billion, giving a free cash flow of -3.65 billion.

Operating Cash Flow	-2.42B
Capital Expenditures	-1.23B
Free Cash Flow	-3.65B
FCF Per Share	-308.10

Full Cash Flow Statement

Margins

Gross margin is 49.30%, with operating and profit margins of -34.50% and -45.39%.

Gross Margin	49.30%
Operating Margin	-34.50%
Pretax Margin	-37.36%
Profit Margin	-45.39%
EBITDA Margin	-23.05%
EBIT Margin	-34.50%
FCF Margin	n/a

Dividends & Yields

S.Biomedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.53%
Shareholder Yield	n/a
Earnings Yield	-2.54%
FCF Yield	-1.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S.Biomedics has an Altman Z-Score of 5.46 and a Piotroski F-Score of 2.

Altman Z-Score	5.46
Piotroski F-Score	2